Brian T. Powl is Chief Commercial Officer of Kura Oncology Inc.
Person profile
Roles
Kura Oncology
Chief Commercial Officer
Fate Therapeutics
Chief Commercial Officer
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | KURA Kura Oncology | Common Stock | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 15,000 |
2 Jan 24 | KURA Kura Oncology | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 15.36 | 30,000 | 460.80 k | 30,000 |
14 Aug 23 | KURA Kura Oncology | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 11.72 | 200,000 | 2.34 mm | 200,000 |
6 Feb 23 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.77 | 425,000 | 2.88 mm | 425,000 |